ArticleCancers2021

The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer.

Julie Labrosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.